Published in Nature on February 20, 2013
miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature (2014) 2.26
Adult-specific functions of animal microRNAs. Nat Rev Genet (2013) 1.89
Hippo signaling impedes adult heart regeneration. Development (2013) 1.81
The role of miRNAs in regulating gene expression networks. J Mol Biol (2013) 1.74
Crucial Role of miR-433 in Regulating Cardiac Fibrosis. Theranostics (2016) 1.66
miR-34: from bench to bedside. Oncotarget (2014) 1.59
MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction. Circ Res (2015) 1.58
The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol (2014) 1.47
Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization. J Am Coll Cardiol (2015) 1.46
microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration. PLoS One (2016) 1.46
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget (2013) 1.43
Atrial fibrillation and microRNAs. Front Physiol (2014) 1.31
Oxidative stress and epigenetic regulation in ageing and age-related diseases. Int J Mol Sci (2013) 1.25
Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 1.17
Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol (2013) 1.11
Genetics and epigenetics of aging and longevity. Cell Cycle (2014) 1.07
Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction. Biomed Res Int (2014) 1.07
c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. Mol Cell Biol (2014) 1.06
Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol (2015) 1.04
Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair. ACS Nano (2014) 1.03
Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res (2014) 1.03
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells. PLoS One (2014) 1.01
Aging and Autophagy in the Heart. Circ Res (2016) 1.00
Functional role of Calstabin2 in age-related cardiac alterations. Sci Rep (2014) 0.99
Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code. Proc Natl Acad Sci U S A (2014) 0.97
The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology. Eur Heart J (2014) 0.97
Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction. Int J Mol Sci (2015) 0.96
Oligoasthenoteratozoospermia and infertility in mice deficient for miR-34b/c and miR-449 loci. PLoS Genet (2014) 0.96
Genome-wide profiling of the microRNA-mRNA regulatory network in skeletal muscle with aging. Aging (Albany NY) (2014) 0.96
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PLoS One (2014) 0.95
TREM2 signaling, miRNA-34a and the extinction of phagocytosis. Front Cell Neurosci (2013) 0.94
Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease. Cells (2014) 0.94
Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol (2015) 0.93
PNUTS/PP1 regulates RNAPII-mediated gene expression and is necessary for developmental growth. PLoS Genet (2013) 0.91
Heat shock improves Sca-1+ stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway. Stem Cells (2014) 0.91
Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling. J Mol Cell Cardiol (2015) 0.91
miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity. PLoS One (2014) 0.90
Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction. Int J Mol Sci (2014) 0.90
MicroRNA profiling of pericardial fluid samples from patients with heart failure. PLoS One (2015) 0.88
Macro advances in microRNAs and myocardial regeneration. Curr Opin Cardiol (2014) 0.88
Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice. Diabetologia (2015) 0.88
MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice. Fibrogenesis Tissue Repair (2013) 0.88
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death. Cell Death Dis (2014) 0.88
A miR-34a-Numb Feedforward Loop Triggered by Inflammation Regulates Asymmetric Stem Cell Division in Intestine and Colon Cancer. Cell Stem Cell (2016) 0.88
Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence. Cardiovasc Res (2015) 0.88
A transgenic resource for conditional competitive inhibition of conserved Drosophila microRNAs. Nat Commun (2015) 0.87
Exercise training in hypertension: Role of microRNAs. World J Cardiol (2014) 0.87
Regulation of SIRT1 by microRNAs. Mol Cells (2013) 0.86
Quantitative proteomic analysis of gene regulation by miR-34a and miR-34c. PLoS One (2014) 0.85
Identification and characterization of microRNAs in Baylisascaris schroederi of the giant panda. Parasit Vectors (2013) 0.85
Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update. Front Aging Neurosci (2014) 0.85
Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3. Antioxid Redox Signal (2014) 0.84
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis. PLoS One (2016) 0.83
miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. Physiol Genomics (2013) 0.83
Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs. J Physiol (2016) 0.83
Dicer expression exhibits a tissue-specific diurnal pattern that is lost during aging and in diabetes. PLoS One (2013) 0.83
Abrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase. Stem Cells (2015) 0.83
Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients. Biomed Res Int (2015) 0.82
The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opin Ther Targets (2015) 0.82
MicroRNAs in cardiovascular ageing. J Physiol (2015) 0.82
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov (2016) 0.82
Role of microRNAs in Alcohol-Induced Multi-Organ Injury. Biomolecules (2015) 0.82
Impact of miRNAs on cardiovascular aging. J Geriatr Cardiol (2015) 0.82
Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells. Stem Cell Res Ther (2015) 0.82
Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries. J Mol Cell Cardiol (2015) 0.81
MicroRNAs in vascular tissue engineering and post-ischemic neovascularization. Adv Drug Deliv Rev (2015) 0.81
MicroRNA-34a: a new piece in the cardiac aging puzzle. Circ Cardiovasc Genet (2013) 0.81
MicroRNAs Inducing Proliferation of Quiescent Adult Cardiomyocytes. Cardiovasc Regen Med (2015) 0.81
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease. Genes Dis (2014) 0.81
A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division. Elife (2016) 0.80
Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs. Cereb Cortex (2014) 0.80
Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. Biomaterials (2015) 0.80
Human cardiospheres as a source of multipotent stem and progenitor cells. Stem Cells Int (2013) 0.80
Desregulated microRNAs in aging-related heart failure. Front Genet (2014) 0.80
Systems analysis reveals down-regulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy. Mol Biosyst (2014) 0.80
The code of non-coding RNAs in lung fibrosis. Cell Mol Life Sci (2015) 0.80
Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy. PLoS One (2014) 0.80
Non-coding RNAs in cardiac regeneration. Oncotarget (2015) 0.79
MicroRNA delivery for regenerative medicine. Adv Drug Deliv Rev (2015) 0.79
MicroRNAs in right ventricular (dys)function (2013 Grover Conference series). Pulm Circ (2014) 0.79
MicroRNAs in the Stressed Heart: Sorting the Signal from the Noise. Cells (2014) 0.79
Up-regulation of microRNA-135a protects against myocardial ischemia/reperfusion injury by decreasing TXNIP expression in diabetic mice. Am J Transl Res (2015) 0.79
Emerging Roles for MicroRNAs in Perioperative Medicine. Anesthesiology (2016) 0.79
Keep PNUTS in your heart. Circ Res (2013) 0.79
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015). Stem Cell Res Ther (2016) 0.79
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. Oncotarget (2016) 0.78
Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis? Mol Ther (2015) 0.78
miRNAGE-34 induces cardiac damAGE. Cell Res (2013) 0.78
The role of microRNAs in cardiac development and regenerative capacity. Am J Physiol Heart Circ Physiol (2015) 0.78
Cardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs. Circ Cardiovasc Genet (2015) 0.78
Adipose Tissue Lipolysis Promotes Exercise-induced Cardiac Hypertrophy Involving the Lipokine C16:1n7-Palmitoleate. J Biol Chem (2015) 0.78
Phosphatase 1 nuclear targeting subunit is an essential regulator of M-phase entry, maintenance, and exit. J Biol Chem (2014) 0.78
Association between pre-miR-27a functional polymorphism and risk of colorectal cancer in north Chinese Han population. Onco Targets Ther (2015) 0.78
MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol (2016) 0.78
miR-146a is upregulated during retinal pigment epithelium (RPE)/choroid aging in mice and represses IL-6 and VEGF-A expression in RPE cells. J Clin Exp Ophthalmol (2016) 0.78
Small RNA Detection by in Situ Hybridization Methods. Int J Mol Sci (2015) 0.77
Exosome and its roles in cardiovascular diseases. Heart Fail Rev (2015) 0.77
Small solutions to big problems: microRNAs for cardiac regeneration. Circ Res (2013) 0.77
miR-34a and the cardiomyopathy of senescence: SALT PNUTS, SALT PNUTS! Cell Metab (2013) 0.77
Integromics network meta-analysis on cardiac aging offers robust multi-layer modular signatures and reveals micronome synergism. BMC Genomics (2015) 0.77
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
Telomere measurement by quantitative PCR. Nucleic Acids Res (2002) 18.69
Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics (2003) 16.60
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature (2008) 10.73
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A (2008) 9.86
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A (2003) 9.14
Telomere dysfunction induces metabolic and mitochondrial compromise. Nature (2011) 6.36
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A (2008) 6.24
Pervasive roles of microRNAs in cardiovascular biology. Nature (2011) 6.08
p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (1999) 5.89
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science (2009) 5.07
Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A (1999) 2.97
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ (2009) 2.80
MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer (2012) 2.78
Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol (1985) (2007) 2.52
Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev (2002) 2.29
Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 2.19
Telomere length measurements using digital fluorescence microscopy. Cytometry (1999) 2.03
MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res (2011) 2.01
Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circ Res (2005) 1.95
Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis. Cancer Biol Ther (2008) 1.94
MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell (2011) 1.84
MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab (2010) 1.73
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A (2012) 1.72
Production and purification of recombinant adeno-associated virus. Methods Enzymol (2000) 1.66
MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun (2010) 1.58
TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs. Nat Struct Mol Biol (2009) 1.51
Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci U S A (2003) 1.37
Disparities in myocardial infarction case fatality rates among the elderly: the 20-year Medicare experience. Am Heart J (2008) 1.29
MicroRNAs in age-related diseases. EMBO Mol Med (2013) 1.20
BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun (2011) 1.11
The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response. EMBO Rep (2010) 1.10
Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. Eur Heart J (2010) 1.04
Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol (2012) 0.97
Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice. Hum Gene Ther (2012) 0.91
Universal definition of myocardial infarction. Circulation (2007) 11.69
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Endothelial progenitor cells: characterization and role in vascular biology. Circ Res (2004) 7.91
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle (2007) 7.00
Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med (2006) 6.77
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 6.50
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med (2003) 6.09
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol (2012) 5.12
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res (2007) 5.09
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science (2009) 5.07
Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res (2008) 4.95
Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J (2006) 4.69
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol (2005) 4.67
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation (2005) 4.49
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Hypertrophy of the heart: a new therapeutic target? Circulation (2004) 4.45
Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation (2003) 4.36
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle (2008) 4.35
Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest (2005) 4.25
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res (2012) 4.19
Soluble CD40 ligand in acute coronary syndromes. N Engl J Med (2003) 4.06
Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J (2007) 3.98
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol (2004) 3.84
Endothelial function: cardiac events. Circulation (2005) 3.80
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest (2005) 3.66
Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A (2002) 3.55
Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol (2004) 3.50
High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation (2008) 3.46
CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation (2002) 3.38
Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2). Blood (2002) 3.38
SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev (2007) 3.34
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation (2002) 3.34
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation (2004) 3.26
Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem (2009) 3.24
Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol (2008) 3.15
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle (2011) 3.15
Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood (2003) 2.93
Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med (2004) 2.80
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood (2010) 2.80
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res (2012) 2.78
Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res (2007) 2.71
Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation (2003) 2.69
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation (2006) 2.67
The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A (2009) 2.66
Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation (2003) 2.63
CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res (2005) 2.62
Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res (2014) 2.60
Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation (2006) 2.58
Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation (2003) 2.52
Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation (2004) 2.51
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature (2011) 2.47
Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res (2005) 2.47
Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet (2011) 2.45
Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol (2007) 2.43